All News

Patients increasingly are looking for healthcare providers that offer digital services, but many still fail to do so.

Obama administration officials have warned that ambitious experiments run by the health law's $10 billion innovation lab wouldn't always be successful. Now there is evidence their caution was well placed.

Population health management programs are paying off, according to a survey of healthcare managers. More than half of respondents expect to recoup investments into these programs within 3 to 4 years, KPMG LLP found.

For years, one prescription to healthcare woes in the United States has been to shift costs to consumers, on the theory that this will cause them to make more cost-effective decisions. As this experiment plays out in real life, however, a different reality is unfolding.

Medicare payments for hospice care carried out in an assisted living facility more than doubled from 2007 to 2012, raising questions about the incentives that Medicare provides for hospice care.

Covered California's leader says its decision is only fair to those insurers who took on the risk of a brand new marketplace in 2014. But the state's insurance commissioner says limiting choices is unfair to consumers.

Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.

As the US sits firmly in the middle of peak flu season, a report published in Morbidity and Mortality Weekly Report found that this season's flu vaccine is only 23% effective at preventing the virus.

Marilyn B. Tavenner, the administrator of CMS, announced on Friday that she will be stepping down from her position at the federal agency.

The research, published in JAMA Surgery, analyzed data collected from NCI's SEER database, between 1988 till 2010, on stage 4 CRC patients who had surgery or not for primary tumor resection. Survival data on these patients was then analyzed and associated with their surgical status.

Fears that Americans who signed up for Obamacare were more likely to be sicker than those with employer health programs may have been unfounded, according to data reviewed by Reuters.

The authors of the research say that this information could be especially valuable for the Spanish population: "Even though these variants are rare or not frequent in the population, their frequency is greater in Spain than in other countries."

Overall, metabolic syndrome was associated with a 39 percent to 103 percent increased risk of endometrial cancer in women 65 and older, according to the study.

The aging US population means that Medicare is taking care of more older, sicker people for longer periods of time. Population trends suggest this phenomenon will only increase, unless drastic management and healthcare delivery solutions are found.

With the dawn of the modern era of new chemotherapeutic and biologic agents available for managing their disease, patients with metastatic colorectal cancer are undergoing less surgery for the removal of their primary tumors.

Expanded insurance coverage has not only brought a significant decline to the uninsured rate, but also reduced cost-related access to care issues, according to the Commonwealth Fund Biennial Health Insurance Survey, 2014.

In an Ope-Ed in The New York Times , Peter Bach, MD, from the Memorial Sloan Kettering Cancer Center, questions the rising drug prices and contemplates solutions.

Members of the ASCO Government Relations Committee are busy meeting Members of Congress as well as State Affiliates to address a number of healthcare issue early in the year.

The United States could save approximately $375 billion annually by simplifying the nation's complex, multi-payer way of financing care, according to a study published in BMC Health Services Research.

Livonia, Michigan-based Trinity Health and Marina del Rey, California-based Heritage Provider Network announced an agreement to form a population health joint venture, called Trinity Health Partners.

The NCQA rating was awarded for Joslin's responsiveness to patients and medical colleagues, cooperation and integration with other healthcare groups, and dedication to improvement. Joslin and AJMC will present "Patient-Centered Diabetes Care 2015" in Boston April 16-17, 2015.

Involving the pharmacy benefits manager earlier in the decision-making process could lead to cost savings on cancer treatments, Express Scripts Chief Executive Officer George Paz said at the J.P. Morgan Healthcare Conference in San Francisco, California.

Hospitals have endorsed the movement toward Regional Care Organizations (RCOs), which would guide the transition away from fee-for-service. But a looming budget gap is an immediate concern, while Alabama's Medicaid costs keep climbing.

In addition to recommendations on alternate techniques, the revised guideline, being jointly developed by CAP, IASLC, and AMP, will also include testing for emerging biomarkers in lung cancer.

After their decision to include Abbvie's triple combination for hepatitis C on their formulary, over Gilead's more expensive regimens, Express Scripts indicated at the J. P. Morgan Healthcare Conference that they'll continue the stance of choosing treatments that are equally effective but save costs, especially in cancer.

The retrospective analysis of 145 patients with stage 2-3 rectal cancer found that the "wait and watch" approach, instead of surgery, in patients treated with chemotherapy might work just as well when measuring survival as an outcome.

Older adults with diabetes are being overtreated for their condition, leading to harmful outcomes such as hypoglycemia, according to a study published in JAMA Internal Medicine.

The increasing popularity of retail clinics to provide basic care is bring driven by many factors, including consumer interest in transparency, cost, and convenience. Malls are beneficiaries of the shift.

Merck and Eli Lilly have entered an agreement to collaborate on clinical trials to evaluate the former's recently approved PD-1 inhibitor, Keytruda (pembrolizumab) in combination with Lilly's oncology agents in several clinical trials targeting multiple tumor types.

The US Supreme Court on Monday declined to take up another broad challenge to President Barack Obama's signature healthcare law, this time from the Association of American Physicians and Surgeons and the Alliance for Natural Health USA.